Nugen Medical Devices Inc (NGMD.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 25 | 84 | 35 | 22 | 117 |
| Cost of Goods | 11 | 51 | 14 | 9 | 52 |
| Gross Profit | 14 | 33 | 21 | 13 | 65 |
| Operating Expenses | 1,215 | 1,227 | 1,216 | 1,006 | 905 |
| Operating Income | -1,201 | -1,193 | -1,194 | -993 | -840 |
| Interest Expense | 897 | 850 | 801 | 737 | 671 |
| Other Income | 474 | -3,106 | 124 | -593 | 3,081 |
| Pre-tax Income | -1,625 | -5,149 | -1,871 | -2,323 | 1,569 |
| Income Tax | 0 | 48 | -5 | 4 | 4 |
| Net Income Continuous | -1,625 | -5,198 | -1,867 | -2,327 | 1,566 |
| Net Income | $-1,625 | $-5,198 | $-1,867 | $-2,327 | $1,566 |
| EPS Basic Total Ops | -0.01 | -0.03 | -0.01 | -0.01 | 0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.03 | -0.01 | -0.01 | 0.01 |
| EPS Diluted Total Ops | -0.01 | -0.03 | -0.01 | -0.01 | 0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.03 | -0.01 | -0.01 | 0.01 |
| EBITDA(a) | $-561 | $-4,099 | $-901 | $-1,422 | $2,398 |